���ϸ�����

This new technology includes three-dimensional ultrasound imaging to better detect prostate cancer.

New study is first to show the “switchboard” role played by specialized nerve cells in the cortex.

Dr. Rachel Bluebond-Langner joins ���ϸ����� Langone to expand program for transgender individuals.

More than 500 New York City professionals attended the event.

Using a test for measuring autoimmunity, experts may be able to evaluate new treatment options.

Enabling people to be treated without repeat clinic visits, new therapy may improve quality of life.

A new, noninvasive procedure helps relieve symptoms due to an enlarged prostate.

New study explains the gene’s role in “fear extinction.”

A drug that keeps cancer cells from multiplying also amplifies the immune system’s attack on tumors.

Surgeon Theodore H. Welling III, MD, will lead ���ϸ����� Langone’s new liver cancer initiative.